1. Home
  2. BEAM vs TNK Comparison

BEAM vs TNK Comparison

Compare BEAM & TNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

N/A

Current Price

$23.08

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Logo Teekay Tankers Ltd.

TNK

Teekay Tankers Ltd.

N/A

Current Price

$89.57

Market Cap

2.5B

ML Signal

N/A

Company Overview

Basic Information
Metric
BEAM
TNK
Founded
2017
2007
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.5B
IPO Year
2019
2007

Fundamental Metrics

Financial Performance
Metric
BEAM
TNK
Price
$23.08
$89.57
Analyst Decision
Strong Buy
Buy
Analyst Count
15
5
Target Price
$49.85
★ $109.00
AVG Volume (30 Days)
★ 1.8M
416.3K
Earning Date
11-03-2026
11-11-2026
Dividend Yield
N/A
★ 1.13%
EPS Growth
★ 82.31
N/A
EPS
N/A
★ N/A
Revenue
★ $24,000.00
N/A
Revenue This Year
N/A
$47.47
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$8.05
Revenue Growth
★ 33.33
N/A
52 Week Low
$20.23
$50.94
52 Week High
$38.26
$110.65

Technical Indicators

Market Signals
Indicator
BEAM
TNK
Relative Strength Index (RSI) 40.33 44.10
Support Level $22.65 $71.28
Resistance Level $28.19 $94.44
Average True Range (ATR) 1.92 4.09
MACD -0.33 -0.65
Stochastic Oscillator 0.07 36.65

Price Performance

Historical Comparison
BEAM
TNK

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

About TNK Teekay Tankers Ltd.

Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.

Share on Social Networks: